Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature

Abstract

Gorham-Stout disease (GSD) is an exceedingly rare disease characterized by progressive osteolysis and angiomatosis. We investigate the features of this disease and evaluate the effects of bisphosphonates (BPs) on it. The clinical, radiological, and pathological characteristics of 12 patients diagnosed with GSD were summarized. Immunohistochemical staining with specific lymphatic endothelial markers (D2-40), vascular markers (CD 31, CD 34), and vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor 3 (VEGFR-3) was performed in specimens of bone biopsy. Patients were treated with either BPs or conjunction therapy of radiation and BPs. The effects of BPs were evaluated by the change of radiological progression, bone mineral density (BMD) and bone turnover biomarkers. To further evaluate the prognosis, a literature review was done. Idiopathic massive osteolysis was found in all patients, including 11 polyostotic and one mono-ostotic osteolysis. Soft tissue lymphangioma was presented in four patents. Four patients were complicated with chylothorax. Endothelial cells lining the proliferative vessels were positive for CD31 and CD34 and D2-40. Mild expression of VEGF and VEGFR-3 was also revealed. Stabilization in osteolysis and improvement in BMD were observed after single therapy with BPs or combined with radiotherapy. High mortality rate was found in patients with chylothorax. Spontaneous, progressive osteolysis is the most typical sign of GSD. BPs and radiotherapy can contribute to the clinical stabilization in bone lesion of GSD. The complicated chylothorax possibly indicates poor prognosis.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Jackson J (1838) A boneless arm. Boston Med Surg J 18:368–369

    Article  Google Scholar 

  2. 2.

    Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37:985–1004

    PubMed  Google Scholar 

  3. 3.

    Motamedi MH, Homauni SM, Behnia H (2003) Massive osteolysis of the mandible: a case report. J Oral Maxillofac Surg 61:957–963

    Article  PubMed  Google Scholar 

  4. 4.

    Takahashi A, Ogawa C, Kanazawa T, Watanabe H, Suzuki M, Suzuki N, Tsuchida Y, Morikawa A, Kuwano H (2005) Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome. J Pediatr Surg 40:47–50

    Article  Google Scholar 

  5. 5.

    Grunewald TG, Damke L, Maschan M, Petrova U, Surianinova O, Esipenko A, Konovalov D, Behrends U, Schiessl J, Wörtler K, Burdach S, von Luettichau I (2010) First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 21(8):1733–1734. doi:10.1093/annonc/mdq331

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Nir V, Guralnik L, Livnat G, Bar-Yoseph R, Hakim F, Ilivitzki A, Bentur L (2013) Propranolol as a treatment option in Gorham-Stout syndrome: a case report. Pediatr Pulmonol 49(4):417–419. doi:10.1002/ppul.22869

    Article  PubMed  Google Scholar 

  7. 7.

    Brodszki N, Lansberg JK, Dictor M, Gyllstedt E, Ewers SB, Larsson MK, Eklund EA (2011) A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr 100(11):1448–1453. doi:10.1111/j.1651-2227.2011.02361.x

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57(6):1018–1024. doi:10.1002/pbc.23124

    Article  PubMed  Google Scholar 

  9. 9.

    Heffez L, Doku HC, Carter BL, Feeney JE (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55:331–343

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Edwards JR, Williams K, Kindblom LG, Meis-Kindblom JM, Hogendoorn PC, Hughes D, Forsyth RG, Jackson D, Athanasou NA (2008) Lymphatics and bone. Hum Pathol 39:49–55

    Article  PubMed  Google Scholar 

  11. 11.

    Morley JE, Dawson M, Hodgkinson H, Kalk WJ (1977) Galactorrhea and hyperprolactinemia associated with chest wall injury. J Clin Endocrinol Metab 45:931–935

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Dellinger MT, Garg N, Olsen BR (2014) Viewpoints on vessels and vanishing bones in Gorham-Stout disease. Bone 63C:47–52. doi:10.1016/j.bone.2014.02.011

    Article  Google Scholar 

  13. 13.

    Heyden G, Kindblom LG, Nielsen JM (1977) Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am 59:57–61

    CAS  PubMed  Google Scholar 

  14. 14.

    Lala S, Mulliken JB, Alomari AI, Fishman SJ, Kozakewich HP, Chaudry G (2013) Gorham-Stout disease and generalized lymphatic anomaly—clinical, radiologic, and histologic differentiation. Skeletal Radiol 42:917–924. doi:10.1007/s00256-012-1565-4

    Article  PubMed  Google Scholar 

  15. 15.

    Tilling G, Skobowytsh B (1968) Disappearing bone disease, morbus Gorham. Report of a case. Acta Orthop Scand 39:398–406

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Moller G, Gruber H, Priemel M, Werner M, Kuhlmey AS, Delling G (1999) Gorham-Stout idiopathic osteolysis—a local osteoclastic hyperactivity? Pathologe 20:177–182

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81:1893–1897

    CAS  PubMed  Google Scholar 

  18. 18.

    Colucci S, Taraboletti G, Primo L, Viale A, Roca C, Valdembri D, Geuna M, Pagano M, Grano M, Pogrel AM, Harris AL, Athanasou NN, Mantovani A, Zallone A, Bussolino F (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21:207–218

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Dupond JL, Bermont L, Runge M, de Billy M (2010) Plasma VEGF determination in disseminated lymphangiomatosis-Gorham-Stout syndrome: a marker of activity? A case report with a 5-year follow-up. Bone 46:873–876. doi:10.1016/j.bone.2009.11.015

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460–476. doi:10.1016/j.cell.2010.01.045

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Kotecha R, Mascarenhas L, Jackson HA, Venkatramani R (2012) Radiological features of Gorham’s disease. Clin Radiol 67:782–788. doi:10.1016/j.crad.2012.01.009

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Cano B, Insa S, Cifrian C, Cortina H, Hernandez M (2006) Radiologic findings in Gorham-Stout syndrome. Radiologia 48:33–36

    Article  PubMed  Google Scholar 

  23. 23.

    Hammer F, Kenn W, Wesselmann U, Hofbauer LC, Delling G, Allolio B, Arlt W (2005) Gorham-Stout disease—stabilization during bisphosphonate treatment. J Bone Miner Res 20:350–353

    Article  PubMed  Google Scholar 

  24. 24.

    Noda M, Endo C, Hoshikawa Y, Ishibashi N, Suzuki T, Okada Y, Kondo T (2013) Successful management of intractable chylothorax in Gorham-Stout disease by awake thoracoscopic surgery. Gen Thorac Cardiovasc Surg 61:356–358. doi:10.1007/s11748-012-0130-3

    Article  PubMed  Google Scholar 

  25. 25.

    Stefanidou M, Ioannidou D, Panayotides J, Tosca A (2004) Cutaneous vascular malformation associated with osteolysis or Gorham’s sign. Int J Dermatol 43:958–961

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Tsang WM, Tong AC, Chow LT, Ng IO (2004) Massive osteolysis (Gorham disease) of the maxillofacial skeleton: report of 2 cases. J Oral Maxillofac Surg 62:225–230

    Article  PubMed  Google Scholar 

  27. 27.

    Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R (2005) Treatment of Gorham’s disease with zoledronic acid. Oral Oncol 41:747–750

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Escande C, Schouman T, Francoise G, Haroche J, Menard P, Piette JC, Bertrand JC, Ruhin-Poncet B (2008) Histological features and management of a mandibular Gorham disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:e30–e37. doi:10.1016/j.tripleo.2008.02.028

    Article  PubMed  Google Scholar 

  29. 29.

    Lehmann G, Pfeil A, Bottcher J, Kaiser WA, Fuller J, Hein G, Wolf G (2009) Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome. Arch Orthop Trauma Surg 129:967–972. doi:10.1007/s00402-008-0742-3

    Article  PubMed  Google Scholar 

  30. 30.

    Kuriyama DK, McElligott SC, Glaser DW, Thompson KS (2010) Treatment of Gorham-Stout disease with zoledronic acid and interferon-alpha: a case report and literature review. J Pediatr Hematol Oncol 32:579–584. doi:10.1097/MPH.0b013e3181edb464

    Article  PubMed  Google Scholar 

  31. 31.

    Pedroletti F, Rangarajan S, McCain JP, Velez I (2010) Conservative treatment of a pathologic fracture in a patient with Gorham-Stout disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:e49–e52. doi:10.1016/j.tripleo.2009.08.045

    Article  PubMed  Google Scholar 

  32. 32.

    Avelar RL, Martins VB, Antunes AA, de Oliveira Neto PJ, Andrade ES (2010) Use of zoledronic acid in the treatment of Gorham’s disease. Int J Pediatr Otorhinolaryngol 74:319–322. doi:10.1016/j.ijporl.2009.12.007

    Article  PubMed  Google Scholar 

  33. 33.

    Garbers E, Reuther F, Delling G (2011) Report of a rare case of Gorham-Stout disease of both shoulders: bisphosphonate treatment and shoulder replacement. Case Rep Rheumatol 2011:565142. doi:10.1155/2011/565142

    PubMed  PubMed Central  Google Scholar 

  34. 34.

    Heyd R, Rabeneck D, Dornenburg O, Tselis N, Zamboglou N (2011) Gorham-Stout syndrome of the pelvic girdle treated by radiation therapy: a case report. Strahlenther Onkol 187:140–143. doi:10.1007/s00066-010-2174-6

    Article  PubMed  Google Scholar 

  35. 35.

    Zheng MW, Yang M, Qiu JX, Nan XP, Huang LY, Zhang WD, Gong L, Huang ZZ (2012) Gorham-Stout syndrome presenting in a 5-year-old girl with a successful bisphosphonate therapeutic effect. Exp Ther Med 4:449–451

    CAS  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Takamoto RM, Armstrong RG, Stanford W, Fontenelle LJ, Troxler G (1971) Chylothorax with multiple lymphangiomata of the bone. Chest 59:687–689

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Tie ML, Poland GA, Rosenow EC (1994) Chylothorax in Gorham’s syndrome. A common complication of a rare disease. Chest 105:208–213

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    De Seze SHA (1956) Osteolyse essentiale scapulo-thoraco-brachiale. Rev Rhum Mal Osteoartic 23(6):517–523

    Google Scholar 

  39. 39.

    Jones GB, Midgley RL, Smith GS (1958) Massive osteolysis: disappearing bones. J Bone Joint Surg Br 40-B:494–501

    CAS  PubMed  Google Scholar 

  40. 40.

    Koblenzer PJ, Bukowski MJ (1961) Angiomatosis (hamartomatous hem-lymphangiomatosis). Report of a case with diffuse involvement. Pediatrics 28:65–76

    CAS  PubMed  Google Scholar 

  41. 41.

    Tucker SM (1967) Bilateral chylothorax with multiple osteolytic lesions? Generalized abnormality of lymphatic system. Proc R Soc Med 60:17–19

    CAS  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Morphis LG, Arcinue EL, Krause JR (1970) Generalized lymphangioma in infancy with chylothorax. Pediatrics 46:566–575

    CAS  PubMed  Google Scholar 

  43. 43.

    Touraine RT, Balander AM (1970) Chylothorax et maladie de Gorham. Lyon Med 224:459–466

    CAS  PubMed  Google Scholar 

  44. 44.

    Kolpakova LV, Iaroshevskaia EN (1967) A case of massive regional osteolysis. Arkh Patol 29:75–77

    CAS  PubMed  Google Scholar 

  45. 45.

    Nozicka Z, Herout V, Fingerland A (1974) Gorham-Stout syndrome caused by hemangiolymphangioma. Cesk Patol 10:56–62

    CAS  PubMed  Google Scholar 

  46. 46.

    Choma ND, Biscotti CV, Bauer TW, Mehta AC, Licata AA (1987) Gorham’s syndrome: a case report and review of the literature. Am J Med 83:1151–1156

    CAS  Article  PubMed  Google Scholar 

  47. 47.

    Dickson GR, Mollan RA, Carr KE (1987) Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease. Histochemistry 87:569–572

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Joseph J, Bartal E (1987) Disappearing bone disease: a case report and review of the literature. J Pediatr Orthop 7:584–588

    CAS  Article  PubMed  Google Scholar 

  49. 49.

    Marymont JV (1987) Comparative imaging. Massive osteolysis (Gorham’s syndrome, disappearing bone disease). Clin Nucl Med 12:153–154

    CAS  Article  PubMed  Google Scholar 

  50. 50.

    Lee S, Finn L, Sze RW, Perkins JA, Sie KC (2003) Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg 129:1340–1343

    Article  PubMed  Google Scholar 

  51. 51.

    Heyd R, Micke O, Surholt C, Berger B, Martini C, Fuller J, Schimpke T, Seegenschmiedt MH (2011) German Cooperative Group on Radiotherapy for Benign D. Radiation therapy for Gorham-Stout syndrome: results of a national patterns-of-care study and literature review. Int J Radiat Oncol Biol Phys 81:e179–e185

    Article  PubMed  Google Scholar 

  52. 52.

    Pfleger A, Schwinger W, Maier A, Tauss J, Popper HH, Zach MS (2006) Gorham-Stout syndrome in a male adolescent-case report and review of the literature. J Pediatr Hematol Oncol 28(4):231–233

    Article  PubMed  Google Scholar 

  53. 53.

    Yildiz TS, Kus A, Solak M, Toker K (2009) The Gorham-Stout syndrome: one lung ventilation with a bronchial blocker. A case of Gorham’s disease with chylothorax. Pediatr Anaesth 19(2):190–191. doi:10.1111/j.1460-9592.2008.02832.x

    Article  Google Scholar 

  54. 54.

    Kose M, Pekcan S, Dogru D, Akyuz C, Ozcelik U, Ozsurekci Y, Gulhan B, Demiricin M, Kiper N (2009) Gorham-Stout syndrome with chylothorax: successful remission by interferon alph-2b. Pediatr Pulmonol 44(6):613–615. doi:10.1002/ppul.20849

    Article  PubMed  Google Scholar 

  55. 55.

    De Smet K, De MAesenner M, Huijssen-Huisman E, Van Gorp B (2010) A rare cause of dyspnea due to chylothorax. Emerg Radiol 17(6):503–505. doi:10.1007/s10140-010-0898-3

    Article  PubMed  Google Scholar 

  56. 56.

    Wijesinghe N, Lin Z, Swarbrick MJ, Jogia DM (2010) Cardiovascular images. Chylotamponade: an unusual manifestation of Gorham-Stout syndrome. Circ Cardiovasc Imaging 3(2):223–224. doi:10.1161/CIRCIMAGING.109.877548

    Article  PubMed  Google Scholar 

  57. 57.

    Bridszki N, Lansberg JK, Dictor M, Gyllstedt E, Ewers SB, Larsson MK, Eklund EA (2011) A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr 100(11):1448–1453. doi:10.1111/j.1651-2227.2011.02361.x

    Article  Google Scholar 

  58. 58.

    Hopmman SM, Van Rijn RR, Eng C, Bras J, Alders M, van der Horst CM, Hennekam RC, Merks JH (2012) PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon. Am J Med Genet A 158A(7):1719–23. doi:10.1002/ajmg.a.35406

Download references

Acknowledgments

We thank the support of the National Natural Science Foundation of China (81100623).

Disclosures

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mei Li.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Zhong, D., Zhou, P. et al. Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature. Clin Rheumatol 35, 813–823 (2016). https://doi.org/10.1007/s10067-014-2780-2

Download citation

Keyword

  • Bisphosphonate
  • Gorham-Stout disease
  • Osteolysis
  • Radiotherapy